These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30611582)

  • 1. Analysis of the ROADSTER pivotal and extended-access cohorts shows excellent 1-year durability of transcarotid stenting with dynamic flow reversal.
    Malas MB; Leal Lorenzo JI; Nejim B; Hanover TM; Mehta M; Kashyap V; Kwolek CJ; Cambria R
    J Vasc Surg; 2019 Jun; 69(6):1786-1796. PubMed ID: 30611582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal.
    Kwolek CJ; Jaff MR; Leal JI; Hopkins LN; Shah RM; Hanover TM; Macdonald S; Cambria RP
    J Vasc Surg; 2015 Nov; 62(5):1227-34. PubMed ID: 26506270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes associated with a transcarotid artery revascularization-centered protocol in high-risk carotid revascularizations using the ENROUTE neuroprotection system.
    Wang SK; Fajardo A; Sawchuk AP; Lemmon GW; Dalsing MC; Gupta AK; Murphy MP; Motaganahalli RL
    J Vasc Surg; 2019 Mar; 69(3):807-813. PubMed ID: 30301690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic risk factors increase risk of myocardial infarction with transcarotid artery revascularization in prospective trials.
    Chung J; Kumins NH; Smith J; Motaganahalli RL; Schneider PA; Kwolek CJ; Kashyap VS;
    J Vasc Surg; 2023 Apr; 77(4):1192-1198. PubMed ID: 36563712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporary Reversal of Blood Flow During Transcarotid Artery Revascularization Does Not Change Brain Electrical Activity in Lead-In Cases of the ROADSTER 1 Multicenter Trial.
    King AH; Motaganahalli RL; Siddiqui A; DeRubertis B; Moore WS; DiMuzio P; Eccher MA; Kashyap VS
    J Endovasc Ther; 2018 Dec; 25(6):773-778. PubMed ID: 30191765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative.
    Malas MB; Dakour-Aridi H; Wang GJ; Kashyap VS; Motaganahalli RL; Eldrup-Jorgensen J; Cronenwett JL; Schermerhorn ML
    J Vasc Surg; 2019 Jan; 69(1):92-103.e2. PubMed ID: 29941316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy.
    Kashyap VS; King AH; Foteh MI; Janko M; Jim J; Motaganahalli RL; Apple JM; Bose S; Kumins NH
    J Vasc Surg; 2019 Jul; 70(1):123-129. PubMed ID: 30622007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-center experience of 30-day perioperative and one year clinical outcomes of transcarotid artery revascularization in 100 consecutive patients.
    AbuRahma AF; AbuRahma ZT; Santini A; Beasley M; Davis M; Lee A; Veith C; Roshdy M; Dean LS; Davis E
    Vascular; 2023 Dec; 31(6):1161-1172. PubMed ID: 35634873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular stenting of supra-aortic lesions using a transcarotid retrograde approach and flow reversal: A multicenter case series.
    Balceniuk MD; Hosn MA; Corn RS; DerDerian T; Grimsley BR; Long P; Moore WS; Rossi PJ; Shakir HJ; Siddiqui AH; Spadone DP; Waqas M; Stoner MC
    J Vasc Surg; 2020 Jun; 71(6):2012-2020.e18. PubMed ID: 31740187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The learning curve of transcarotid artery revascularization.
    King AH; Kumins NH; Foteh MI; Jim J; Apple JM; Kashyap VS
    J Vasc Surg; 2019 Aug; 70(2):516-521. PubMed ID: 30718112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial.
    Kashyap VS; So KL; Schneider PA; Rathore R; Pham T; Motaganahalli RL; Massop DW; Foteh MI; Eckstein HH; Jim J; Leal Lorenzo JI; Melton JG
    J Vasc Surg; 2022 Aug; 76(2):466-473.e1. PubMed ID: 35381327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation transcarotid artery revascularization: TransCarotid flOw Reversal Cerebral Protection And CGUARD MicroNET-Covered Embolic Prevention Stent System To Reduce Strokes - TOPGUARD Study.
    Trystula M; VAN Herzeele I; Kolvenbach R; Tekieli L; Fonteyne C; Mazurek A; Dzierwa K; Chmiel J; Lindsay J; Kwiatkowski T; Hydzik A; Oplawski M; Bederski K; Musialek P
    J Cardiovasc Surg (Torino); 2024 Jun; 65(3):181-194. PubMed ID: 39007552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease.
    Kashyap VS; Schneider PA; Foteh M; Motaganahalli R; Shah R; Eckstein HH; Henao S; LaMuraglia G; Stoner MC; Melton J; Massop D; Hanover T; Titus J; Moore WS; Rodríguez-Carvajal R; Malas MB; Arko FR; Pierce D; Anain P; Oskin T;
    Stroke; 2020 Sep; 51(9):2620-2629. PubMed ID: 32811386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system.
    Malas MB; Leal J; Kashyap V; Cambria RP; Kwolek CJ; Criado E
    J Vasc Surg; 2017 Mar; 65(3):916-920. PubMed ID: 28236931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary mechanism of stroke reduction in transcarotid artery revascularization is dynamic flow reversal.
    Naazie IN; Magee GA; Mathlouthi A; Elsayed N; Dakour-Aridi H; Malas MB
    J Vasc Surg; 2021 Jul; 74(1):187-194. PubMed ID: 33276041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of transfemoral carotid artery stenting and transcarotid artery revascularization for restenosis after prior ipsilateral carotid endarterectomy.
    Chang H; Rockman CB; Veith FJ; Kashyap VS; Jacobowitz GR; Sadek M; Garg K; Maldonado TS
    J Vasc Surg; 2022 Feb; 75(2):561-571.e3. PubMed ID: 34506900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of age on in-hospital outcomes after transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy.
    Dakour-Aridi H; Kashyap VS; Wang GJ; Eldrup-Jorgensen J; Schermerhorn ML; Malas MB
    J Vasc Surg; 2020 Sep; 72(3):931-942.e2. PubMed ID: 32035784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propensity score-matched analysis of 1-year outcomes of transcarotid revascularization with dynamic flow reversal, carotid endarterectomy, and transfemoral carotid artery stenting.
    Malas MB; Elsayed N; Naazie I; Dakour-Aridi H; Yei KS; Schermerhorn ML
    J Vasc Surg; 2022 Jan; 75(1):213-222.e1. PubMed ID: 34500027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic eligibility for transcarotid artery revascularization and transfemoral carotid artery stenting.
    Wu WW; Liang P; O'Donnell TFX; Swerdlow NJ; Li C; Wyers MC; Schermerhorn ML
    J Vasc Surg; 2019 May; 69(5):1452-1460. PubMed ID: 30853384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female and male patients have similar outcomes after transcarotid artery revascularization in prospective trials.
    Smith JA; Chung JM; Schneider PA; Kwolek CJ; Arko FR; Henao S; Titus J; DiMuzio P; Roddy S; Farber MA; Kashyap VS;
    J Vasc Surg; 2024 Jan; 79(1):81-87.e1. PubMed ID: 37716579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.